Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Mirror trick may ease Post-Stroke pain

NCT ID NCT07537465

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether mirror therapy can reduce pain and improve movement in stroke patients who also have complex regional pain syndrome (CRPS). Forty adults who had a stroke within the past year and were diagnosed with CRPS took part. They received either real mirror therapy or a sham version for 20 minutes daily over 4 weeks, alongside standard rehab. The goal was to see if the therapy could ease pain, reduce swelling, and improve arm function.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Oct 2022

Finished

Oct 2023

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with a first-ever ischemic or hemorrhagic stroke * Time since stroke onset of ≤ 12 months * Diagnosed with Complex Regional Pain Syndrome (CRPS) Type 1 according to the Budapest criteria * In the dystrophic stage (Stage 2) of CRPS * Mini-Mental State Examination (MMSE) score \> 24 * Brunnstrom upper extremity-hand stage between 1 and 4 * Age between 18 and 65 years Exclusion Criteria: * Unstable medical condition * Presence of neglect * Severe aphasia preventing completion of assessment scales * Presence of a concomitant lower motor neuron lesion * History of fracture, surgery, or amputation in the affected limb * Presence of implanted electronic devices (e.g., cardiac pacemaker) * Local infection at the application site * Use of oral steroids or pregabalin/gabapentin within the last 3 months * History of intra-articular injection, botulinum toxin injection, or suprascapular nerve block within the last 3 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Complex regional pain syndrome I (CRPS I) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Başakşehir Çam&Sakura City Hospital

    Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.